References

The prevalence of age-related eye diseases and visual impairment in aging: current estimates

10.1167/iovs.13-12789 · 2013 · External reference

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors

10.1186/s40662-016-0063-5 · 2016 · External reference

Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity

10.1016/s0161-6420(97)30079-7 · 1997 · External reference

Cone- and rod-mediated dark adaptation impairment in age-related maculopathy

10.1016/j.ophtha.2006.12.023 · 2007 · External reference

Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration

10.1016/j.ophtha.2008.03.009 · 2008 · External reference

Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration

10.1001/jamaophthalmol.2014.5963 · 2015 · External reference

Longitudinal study of visual function in dry age-related macular degeneration at 12 months

10.1016/j.oret.2019.03.010 · 2019 · External reference

Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy

10.1167/iovs.05-1222 · 2006 · External reference

Natural history of geographic atrophy secondary to age-related macular degeneration: results from the prospective Proxima A and B clinical trials

10.1016/j.ophtha.2019.12.009 · 2020 · External reference

Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration

10.1016/j.ophtha.2017.11.036 · 2018 · External reference

Enrichment of macular pigment enhances contrast sensitivity in subjects free of retinal disease: Central Retinal Enrichment Supplementation Trials—report 1

10.1167/iovs.16-19520 · 2016 · External reference

Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR Study

10.1167/iovs.12-10715 · 2013 · External reference

The burden of age-related macular degeneration: A value-based medicine analysis.

2005 · External reference

Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study

10.1016/j.ophtha.2014.03.013 · 2014 · External reference

Prevalence of age-related macular degeneration in the US population

10.1001/archophthalmol.2010.318 · 2011 · External reference

Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study

10.1167/iovs.14-14246 · 2014 · External reference

Nitrate-nitrogen levels in rural drinking water: is there an association with age-related macular degeneration?

10.1080/10934529.2013.823323 · 2013 · External reference

Hypertension, cardiovascular disease, and age-related macular degeneration

10.1001/archopht.118.3.351 · 2000 · External reference

Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration

10.1167/iovs.10-5429 · 2010 · External reference

Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration

10.1167/iovs.07-1352 · 2008 · External reference

A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD

10.1016/j.exer.2009.01.017 · 2009 · External reference

The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation

10.1006/exer.2002.2047 · 2002 · External reference

Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD

10.1167/iovs.05-0719 · 2006 · External reference

Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)

10.1016/j.ophtha.2012.11.037 · 2013 · External reference

Inflammation and cell death in age-related macular degeneration: an immunopathological and ultrastructural model

2014 · External reference

Fundus autofluorescence and the bisretinoids of retina

10.1039/c0pp00207k · 2010 · External reference

Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration

10.1016/j.preteyeres.2015.09.002 · 2016 · External reference

Mitochondria: potential targets for protection in age-related macular degeneration

2018 · External reference

Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration

10.1016/j.mam.2012.04.006 · 2012 · External reference

Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration

10.1016/j.exer.2016.01.018 · 2016 · External reference

Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration

10.1016/j.preteyeres.2020.100858 · 2020 · External reference

Investigating mitochondria as a target for treating age-related macular degeneration

10.1523/jneurosci.0190-15.2015 · 2015 · External reference

Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity

10.1167/iovs.04-1224 · 2005 · External reference

Oxidative stress induces mitochondrial dysfunction and a protective unfolded protein response in RPE cells

10.1016/j.freeradbiomed.2014.01.004 · 2014 · External reference

Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E

10.1167/iovs.03-0910 · 2004 · External reference

Unresolved reference

2016 · External reference

The role of mitochondria in AMD: current knowledge and future applications

10.4103/jovr.jovr_182_17 · 2017 · External reference

Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy

10.1016/j.ophtha.2012.10.007 · 2013 · External reference

Structural plasticity of perisynaptic astrocyte processes involves ezrin and metabotropic glutamate receptors

10.1073/pnas.1100957108 · 2011 · External reference

Fine astrocyte processes contain very small mitochondria: glial oxidative capability may fuel transmitter metabolism

10.1007/s11064-015-1563-8 · 2015 · External reference

Beyond polarity: functional membrane domains in astrocytes and Müller cells

10.1007/s11064-012-0824-z · 2012 · External reference

Mitochondrial reactive oxygen species production and elimination

10.1016/j.yjmcc.2014.03.011 · 2014 · External reference

Elamipretide protects RPE and improves mitochondrial function in models of AMD

2017 · External reference

Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis

10.1111/bph.12468 · 2014 · External reference

First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics

10.1111/bph.12461 · 2014 · External reference

Baseline MNREAD measures for normally sighted subjects from childhood to old age

10.1167/iovs.16-19580 · 2016 · External reference

Visual function measures in early and intermediate age-related macular degeneration

10.1097/iae.0000000000001002 · 2016 · External reference

Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration

10.1167/iovs.13-13745 · 2014 · External reference

Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography

10.1016/j.ophtha.2013.07.013 · 2014 · External reference

MultipleTesting.com: a tool for life science researchers for multiple hypothesis testing correction

10.1371/journal.pone.0245824 · 2021 · External reference

Visual function metrics in early and intermediate dry age-related macular degeneration for use as clinical trial endpoints

10.1016/j.ajo.2018.02.012 · 2018 · External reference

A mitochondrial therapeutic reverses visual decline in mouse models of diabetes

2015 · External reference

Improving mitochondrial bioenergetics under ischemic conditions increases warm ischemia tolerance in the kidney

10.1152/ajprenal.00366.2014 · 2015 · External reference

Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis

10.1152/ajprenal.00697.2013 · 2014 · External reference

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy

10.1212/wnl.0000000000005255 · 2018 · External reference

Effects of elamipretide on left ventricular function in patients with heart failure with reduced ejection fraction: the PROGRESS-HF phase 2 trial: effects of elamipretide in heart failure

10.1016/j.cardfail.2020.02.001 · 2020 · External reference

Novel mitochondria-targeting peptide in heart failure treatment

2017 · External reference

Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36

10.1001/jamaophthalmol.2013.6636 · 2014 · External reference